Delayed
Japan Exchange
02:00:00 2024-05-09 am EDT
|
5-day change
|
1st Jan Change
|
2,274
JPY
|
-0.87%
|
|
-1.39%
|
-9.64%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,115,128
|
1,240,811
|
1,442,521
|
1,512,876
|
1,349,755
|
1,077,293
|
-
|
-
|
Enterprise Value (EV)
1 |
1,045,860
|
1,179,553
|
1,378,498
|
1,443,704
|
1,253,600
|
931,752
|
868,648
|
821,387
|
P/E ratio
|
21.6
x
|
21
x
|
19.1
x
|
18.9
x
|
12
x
|
8.35
x
|
9.89
x
|
9.25
x
|
Yield
|
2.07%
|
1.81%
|
1.73%
|
1.83%
|
2.53%
|
3.48%
|
3.53%
|
3.58%
|
Capitalization / Revenue
|
3.86
x
|
4.24
x
|
4.66
x
|
4.19
x
|
3.02
x
|
2.12
x
|
2.23
x
|
2.15
x
|
EV / Revenue
|
3.62
x
|
4.03
x
|
4.46
x
|
4
x
|
2.8
x
|
1.83
x
|
1.8
x
|
1.64
x
|
EV / EBITDA
|
14.4
x
|
12.9
x
|
12.1
x
|
11.9
x
|
7.86
x
|
4.9
x
|
5.45
x
|
4.86
x
|
EV / FCF
|
61.5
x
|
17.7
x
|
84.1
x
|
21.3
x
|
8.64
x
|
7.98
x
|
7.95
x
|
7.4
x
|
FCF Yield
|
1.63%
|
5.65%
|
1.19%
|
4.7%
|
11.6%
|
12.5%
|
12.6%
|
13.5%
|
Price to Book
|
2
x
|
2.21
x
|
2.27
x
|
2.28
x
|
1.82
x
|
1.36
x
|
1.25
x
|
1.15
x
|
Nbr of stocks (in thousands)
|
514,121
|
499,120
|
499,142
|
493,436
|
488,334
|
469,716
|
-
|
-
|
Reference price
2 |
2,169
|
2,486
|
2,890
|
3,066
|
2,764
|
2,294
|
2,294
|
2,294
|
Announcement Date
|
5/9/19
|
5/12/20
|
5/11/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
288,634
|
292,420
|
309,284
|
361,361
|
447,187
|
508,509
|
482,278
|
500,875
|
EBITDA
1 |
72,631
|
91,705
|
114,150
|
120,916
|
159,414
|
190,285
|
159,486
|
169,120
|
EBIT
1 |
62,010
|
77,491
|
98,330
|
103,195
|
141,963
|
172,026
|
144,234
|
153,343
|
Operating Margin
|
21.48%
|
26.5%
|
31.79%
|
28.56%
|
31.75%
|
33.83%
|
29.91%
|
30.62%
|
Earnings before Tax (EBT)
1 |
65,141
|
79,696
|
100,890
|
105,025
|
143,532
|
174,278
|
146,205
|
156,082
|
Net income
1 |
51,539
|
59,704
|
75,425
|
80,519
|
112,723
|
131,657
|
110,352
|
117,397
|
Net margin
|
17.86%
|
20.42%
|
24.39%
|
22.28%
|
25.21%
|
25.89%
|
22.88%
|
23.44%
|
EPS
2 |
100.2
|
118.5
|
151.1
|
162.2
|
230.8
|
274.7
|
231.8
|
248.1
|
Free Cash Flow
1 |
17,011
|
66,682
|
16,391
|
67,867
|
145,113
|
116,781
|
109,314
|
110,969
|
FCF margin
|
5.89%
|
22.8%
|
5.3%
|
18.78%
|
32.45%
|
22.97%
|
22.67%
|
22.16%
|
FCF Conversion (EBITDA)
|
23.42%
|
72.71%
|
14.36%
|
56.13%
|
91.03%
|
61.37%
|
68.54%
|
65.62%
|
FCF Conversion (Net income)
|
33.01%
|
111.69%
|
21.73%
|
84.29%
|
128.73%
|
88.7%
|
99.06%
|
94.52%
|
Dividend per Share
2 |
45.00
|
45.00
|
50.00
|
56.00
|
70.00
|
79.92
|
80.92
|
82.17
|
Announcement Date
|
5/9/19
|
5/12/20
|
5/11/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
149,008
|
143,412
|
150,474
|
-
|
86,714
|
174,077
|
97,353
|
89,931
|
106,722
|
109,979
|
216,701
|
122,319
|
108,167
|
120,016
|
138,697
|
258,713
|
131,190
|
123,574
|
114,880
|
-
|
234,593
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
51,933
|
51,450
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
41,878
|
35,613
|
52,401
|
-
|
28,379
|
58,171
|
23,996
|
21,028
|
38,162
|
42,108
|
80,270
|
42,320
|
19,373
|
41,348
|
55,688
|
97,036
|
47,590
|
31,005
|
36,146
|
-
|
73,306
|
-
|
-
|
Operating Margin
|
28.1%
|
24.83%
|
34.82%
|
-
|
32.73%
|
33.42%
|
24.65%
|
23.38%
|
35.76%
|
38.29%
|
37.04%
|
34.6%
|
17.91%
|
34.45%
|
40.15%
|
37.51%
|
36.28%
|
25.09%
|
31.46%
|
-
|
31.25%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
43,042
|
36,654
|
53,674
|
-
|
28,427
|
59,231
|
25,118
|
20,676
|
39,041
|
41,978
|
81,019
|
43,360
|
19,153
|
42,378
|
56,918
|
99,296
|
47,996
|
24,254
|
36,531
|
-
|
74,076
|
-
|
-
|
Net income
1 |
32,816
|
26,888
|
39,849
|
-
|
22,216
|
46,290
|
18,330
|
15,899
|
29,477
|
32,862
|
62,339
|
33,317
|
17,067
|
31,818
|
42,673
|
74,491
|
36,053
|
25,519
|
27,738
|
-
|
56,247
|
-
|
-
|
Net margin
|
22.02%
|
18.75%
|
26.48%
|
-
|
25.62%
|
26.59%
|
18.83%
|
17.68%
|
27.62%
|
29.88%
|
28.77%
|
27.24%
|
15.78%
|
26.51%
|
30.77%
|
28.79%
|
27.48%
|
20.65%
|
24.15%
|
-
|
23.98%
|
-
|
-
|
EPS
2 |
64.58
|
-
|
79.84
|
-
|
44.51
|
92.74
|
36.87
|
32.58
|
60.37
|
67.30
|
127.7
|
68.23
|
34.95
|
65.16
|
88.17
|
153.3
|
75.75
|
51.98
|
59.70
|
-
|
121.2
|
-
|
-
|
Dividend per Share
2 |
22.50
|
-
|
22.50
|
27.50
|
-
|
28.00
|
-
|
-
|
-
|
-
|
33.00
|
-
|
-
|
-
|
40.00
|
40.00
|
-
|
40.00
|
-
|
45.00
|
-
|
-
|
45.00
|
Announcement Date
|
10/31/19
|
5/12/20
|
10/29/20
|
5/11/21
|
11/1/21
|
11/1/21
|
1/31/22
|
5/11/22
|
8/1/22
|
10/31/22
|
10/31/22
|
1/31/23
|
5/10/23
|
7/31/23
|
11/1/23
|
11/1/23
|
1/31/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
69,268
|
61,258
|
64,023
|
69,172
|
96,155
|
145,541
|
208,645
|
255,906
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
17,011
|
66,682
|
16,391
|
67,867
|
145,113
|
116,781
|
109,314
|
110,969
|
ROE (net income / shareholders' equity)
|
9.5%
|
10.7%
|
12.6%
|
12.5%
|
16.1%
|
17.1%
|
13.2%
|
12.9%
|
ROA (Net income/ Total Assets)
|
10.3%
|
12%
|
14.2%
|
14.1%
|
17.7%
|
15.3%
|
11.5%
|
11.7%
|
Assets
1 |
500,145
|
497,621
|
530,900
|
569,650
|
636,778
|
857,772
|
956,890
|
1,006,935
|
Book Value Per Share
2 |
1,084
|
1,127
|
1,273
|
1,343
|
1,519
|
1,683
|
1,829
|
1,986
|
Cash Flow per Share
2 |
121.0
|
147.0
|
183.0
|
198.0
|
267.0
|
259.0
|
274.0
|
302.0
|
Capex
1 |
22,303
|
7,475
|
7,018
|
5,497
|
14,497
|
22,750
|
22,583
|
22,543
|
Capex / Sales
|
7.73%
|
2.56%
|
2.27%
|
1.52%
|
3.24%
|
4.47%
|
4.68%
|
4.5%
|
Announcement Date
|
5/9/19
|
5/12/20
|
5/11/21
|
5/11/22
|
5/10/23
|
-
|
-
|
-
|
Last Close Price
2,294
JPY Average target price
2,714
JPY Spread / Average Target +18.34% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.64% | 6.92B | | +19.58% | 43.74B | | +21.99% | 22.26B | | +16.41% | 14.9B | | +10.35% | 13.39B | | +44.19% | 12.12B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +12.41% | 5.47B | | +8.29% | 4.83B |
Generic Pharmaceuticals
|